Phase I study of topotecan in combination with temozolomide (TOTEM) in relapsed or refractory paediatric solid tumours
Authors:
- Hervé RubieHRHervé Rubie
- Birgit GeoergerBGBirgit Geoerger
- Didier FrappazDFDidier Frappaz
- Antonin SchmittASAntonin Schmitt
- Pierre LeblondPLPierre Leblond
- Anna NdiayeANAnna Ndiaye
- Isabelle AertsIAIsabelle Aerts
- Marie-Cécile Le DeleyMDMarie-Cécile Le Deley
- Jean-Claude GentetJGJean-Claude Gentet
- Angelo PaciAPAngelo Paci
- Pascal ChastagnerPCPascal Chastagner
- Nathalie DiasNDNathalie Dias
- 1 October 2010
- journal article
- research article
- Published by Elsevier in European Journal of Cancer
- Vol. 46 (15) , 2763-2770
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Phase I Trial of Oral Irinotecan and Temozolomide for Children With Relapsed High-Risk Neuroblastoma: A New Approach to Neuroblastoma Therapy Consortium StudyJournal of Clinical Oncology, 2009
- A phase II study of irinotecan in children with relapsed or refractory neuroblastoma: A European cooperation of the Société Française d’Oncologie Pédiatrique (SFOP) and the United Kingdom Children Cancer Study Group (UKCCSG)European Journal of Cancer, 2008
- Topotecan Is Active Against Wilms’ Tumor: Results of a Multi-Institutional Phase II StudyJournal of Clinical Oncology, 2007
- Irinotecan Plus Temozolomide for Relapsed or Refractory NeuroblastomaJournal of Clinical Oncology, 2006
- Phase II Study of Temozolomide in Relapsed or Refractory High-Risk Neuroblastoma: A Joint Société Française des Cancers de l’Enfant and United Kingdom Children Cancer Study Group–New Agents Group StudyJournal of Clinical Oncology, 2006
- Temozolomide in resistant or relapsed pediatric solid tumorsPediatric Blood & Cancer, 2005
- Efficacy of Topotecan and Cyclophosphamide Given in a Phase II Window Trial in Children With Newly Diagnosed Metastatic Rhabdomyosarcoma: A Children’s Oncology Group StudyJournal of Clinical Oncology, 2004
- A phase II study of topotecan with vincristine and doxorubicin in children with recurrent/refractory neuroblastomaCancer, 2003
- Phase I study of temozolomide and escalating doses of oral etoposide for adults with recurrent malignant gliomaCancer, 2003
- Phase I Trial and Pharmacokinetic (PK) and Pharmacodynamics (PD) Study of Topotecan Using a Five-Day Course in Children with Refractory Solid TumorsJournal of Pediatric Hematology/Oncology, 1996